thyroid bethesda

52
Updating Thyroid Cytopathology: The Bethesda System The Bethesda System P.E. Wakely, Jr., M.D. Ohio State University Cl b Ohi Columbus, Ohio U.S.A.

Upload: dinisha-einstien

Post on 14-Apr-2015

35 views

Category:

Documents


3 download

DESCRIPTION

a detailed description of the bethesda system for reporting thyroid cytopathlogy by dr. wakely

TRANSCRIPT

Page 1: thyroid bethesda

Updating Thyroid Cytopathology: The Bethesda SystemThe Bethesda System

P.E. Wakely, Jr., M.D.Ohio State UniversityC l b OhiColumbus, OhioU.S.A.

Page 2: thyroid bethesda

Thyroid Nodules NEJM June 2007

• FNA: the most specific & sensitive method to select suspicious nodules for surgerynodules for surgery

• in 10-20% of thyroid FNA a precise diagnosis cannot be reached

Page 3: thyroid bethesda

NCI Thyroid FNA State of The S i C fScience Conference

Bethesda, MDOctober, 2007October, 2007

Page 4: thyroid bethesda

Classification Scheme Proposed by 2006ATA 2006

• Inadequate • Non-Diagnostic / UNSATInadequate

li

Non-Diagnostic / UNSAT• Benign

AC S / S• Malignant • ACUS / FLUS• Suspicious for Neoplasm

• Indeterminate – Follicular– Hürthle

• Benign• Suspicious for Malignancy• Malignantg

Page 5: thyroid bethesda

Classification Scheme Proposed by 2006ATA 2006

• Inadequate • Non-Diagnostic / UNSATInadequate

li

Non-Diagnostic / UNSAT• Benign

AC S / S• Malignant • ACUS / FLUS• Suspicious for Neoplasm

• Indeterminate – Follicular– Hürthle

• Benign• Suspicious for Malignancy• Malignantg

Page 6: thyroid bethesda

Clinical Management Algorithms

• Benign • FLUS–follow

• Suspicious– repeat FNAN di ti• Suspicious

–surgery• Non-diagnostic

(includes “cyst fluid • Malignant

surgery

only”)– repeat FNA–surgery repeat FNA

• usually after 3 monthsmonths

Page 7: thyroid bethesda

• This is not a• This is not a “standard of

i id lipractice” guideline nor is it endorsed as such by the NCI.

Page 8: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic/ UnsatisfactoryNondiagnostic/ Unsatisfactory

Page 9: thyroid bethesda

Adequacy - according to the literatureAdequacy according to the literature

• 6 groups each ≥10 benign follicular cells6 groups, each ≥10 benign follicular cells Goellner et al Acta Cytol 1987; 31:587-90

h b i f lli l ll• 10 groups, each ≥20 benign follicular cells Nguyen et al. Pathol Annu 1991;23:63-80

• 6 groups on at least 2 of 6 aspirates Hamburger et

al. Diagn Cytopathol 1988;4:14-17

• 8 groups on at least 2 slides Kini SR. Guides to Clinical

Aspiration Biopsy: Thyroid, 2nd ed. 1996 p p y y

Page 10: thyroid bethesda

Adequacy in FNAAdequacy in FNA

• “The adequacy of FNA is highly dependent onThe adequacy of FNA is highly dependent on the skill and experience of the operator.” http://thyroidfna.cancer.gov

• “Why not accept the obvious? Training in proper technique is crucial for the success ofproper technique is crucial for the success of thyroid aspiration biopsy.” Waisman et al. AJCP 2008; 129:824.

• also dependent on the inherent quality of the lesion, e.g. cystic, solid, calcified, fibrotic, g y , , ,

Page 11: thyroid bethesda

Adequacy CriterionAdequacy Criterion• at least 6 groups of follicular cells

– each with at least 10 benign appearing, well-visualized follicular cellswell visualized follicular cells

• exceptions– thyroiditis–abundant colloidabundant colloid–any atypia

Page 12: thyroid bethesda

Non-Diagnostic

Page 13: thyroid bethesda

Thyroid CystsThyroid Cysts

• result of cystic degeneration of anresult of cystic degeneration of an adenomatous nodule

• risk of malignancy• risk of malignancy– 1- 4% in non-complex cysts

14% i i d lid/ i d l & l– 14% in mixed solid/cystic nodules & large cysts• diagnose as “Cyst Fluid Only” and categorized

as Non-Diagnostic / Unsatisfactory

Page 14: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign

l i k f li ( 1%)– very low risk of malignancy (<1%)– benign follicular nodule [nodular goiter, colloid

d l d t id d l ]nodule, adenomatoid nodule]– lymphocytic (Hashimoto) thyroiditis

b / l h idi i– subacute/granulomatous thyroiditis– amyloid goiter

Page 15: thyroid bethesda
Page 16: thyroid bethesda
Page 17: thyroid bethesda
Page 18: thyroid bethesda

The recognition of abundant colloid shouldThe recognition of abundant colloid should override the requirement of a set number

f f lli l ll th f l tiof follicular cells as the false negative rate of such an aspirate approaches zero. As such, cytological interpretation should be reported as “negative or benign ” and p g g“consistent with a colloid nodule” , not "unsatisfactory" or "nondiagnostic”unsatisfactory or nondiagnostic .

htt //th idfhttp://thyroidfna.cancer.gov

Page 19: thyroid bethesda
Page 20: thyroid bethesda
Page 21: thyroid bethesda
Page 22: thyroid bethesda
Page 23: thyroid bethesda
Page 24: thyroid bethesda
Page 25: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign

A i l C ll f d i d Si ifi /• Atypical Cells of Undetermined Significance / Follicular Lesion of Undetermined Si ifi [FLUS]Significance [FLUS]

Page 26: thyroid bethesda

ACUS/FLUS• set of lesions with architectural/cytologic atypia

but insufficient for a dx of FN• some examples:

– sparsely cellular - but seem to have a predominance of– sparsely cellular - but seem to have a predominance of microfollicles

– atypical cyst lining cellsatypical cyst lining cells– hypocellular aspirate, but nearly all cells are Hürthle

rare cells with features suggesting PTC– rare cells with features suggesting PTC• Bethesda committee: no more 7% of diagnoses

t (80% ) l i t b i t• most (80% or more) resolve into benign category

Page 27: thyroid bethesda
Page 28: thyroid bethesda

Implications of proposed …category of “Follicular lesion of undetermined significance”Follicular lesion of undetermined significance .

Diagn Cytopathol 2009; 37:710.

• 5-year study; 3 medical centers5 year study; 3 medical centers• 6,872 thyroid aspirates; 664=FLUS; 28 pathologists• Range of FLUS diagnosis: 2 5 – 28 6%• Range of FLUS diagnosis: 2.5 28.6%

C l i “FLUS t i• Conclusion: “FLUS category requires more rigorously defined morphologic criteria for it to become a useful guide in clinical management.”g

Page 29: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign

A i l C ll f d i d Si ifi• Atypical Cells of Undetermined Significance• Suspicious for Follicular Neoplasm / Follicular

Neoplasm

Page 30: thyroid bethesda

Suspicious for Follicular NSuspicious for Follicular N

• used for cases where a predominance of• used for cases where a predominance of microfollicles is present [“architectural t i ”]atypia”]

• raises the possibility of Follicular CAp y• distinction between Follicular Adenoma

& Follicular CA not possible with FNA& Follicular CA not possible with FNA cytomorphology

Page 31: thyroid bethesda
Page 32: thyroid bethesda

“ h i b ll bl“The ‘magic bullet’ to enable cytopathologists to segregate follicular y p g g gpatterned neoplasms into benign and

malignant categories, and thus, guide themalignant categories, and thus, guide the therapeutic approach to any individual

thyroid nodule remains to be discovered ”thyroid nodule, remains to be discovered.

• LiVolsi VA, Baloch ZW. Determining the diagnosis and prognosis of thyroid neoplasms: do special studies help? Hum Pathol 1999; 30: 885-6.

Page 33: thyroid bethesda
Page 34: thyroid bethesda

Microfollicular Pattern• monotonous population of follicular cells with

i i l b ll idminimal - absent colloid• nuclear overlapping and crowding are common• cells are usually arranged in three dimensional

groups and µfolliclesg p µ• µfollicle: <15 cells arranged in circle that is at

least two-thirds complete Arch Pathol Lab Med. 2006;130:148.least two thirds complete • nuclear atypia is not required

Page 35: thyroid bethesda
Page 36: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign

A i l C ll f d i d Si ifi• Atypical Cells of Undetermined Significance• Suspicious for Follicular Neoplasm/ Follicular

Neoplasm– Hürthle Cell Neoplasm– “refers to a cellular aspirate that consists

exclusively (or almost exclusively) of y ( y)Hürthle cells”

Page 37: thyroid bethesda
Page 38: thyroid bethesda

Helpful Ancillary Techniques toHelpful Ancillary Techniques to Distinguish Adenoma From

Carcinoma

NONENONE

Page 39: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign• Atypical Cells of Undetermined Significance• Atypical Cells of Undetermined Significance• Suspicious for Neoplasm

– FollicularFollicular– Hürthle

• Suspicious for MalignancySuspicious for Malignancy– quantitatively/qualitatively insufficient

“aim is to preserve the very high PPV of the– aim . . . is to preserve the very high PPV of the malignant category. . . ”

Page 40: thyroid bethesda

Suspicious for MalignancySuspicious for Malignancy

• suspicious for PTCsuspicious for PTC– subtle nuclear features, paucity of cells, unusual

variantvariant • e.g. FVPTC often lacks exhibit classic PTC features

• suspicious for MTC• suspicious for MTC– e.g. insufficient cells to perform IHC for calcitonin

i i f th f f• suspicious for other forms of cancer– e.g. complete necrosis of cellular material

Page 41: thyroid bethesda
Page 42: thyroid bethesda

NCI/Bethesda Conference - Suggested Terminology for Reporting Thyroid FNA

• Nondiagnostic / UnsatisfactoryNondiagnostic / Unsatisfactory• Benign

A i l C ll f d i d Si ifi• Atypical Cells of Undetermined Significance • Suspicious for Neoplasm

– Follicular– Hürthle

• Suspicious for Malignancy• Malignant• Malignant

Page 43: thyroid bethesda

Papillary Thyroid CarcinomaPapillary Thyroid Carcinoma

Page 44: thyroid bethesda

PTC – typical featuresPTC typical features

• syncytial monolayer • intranuclearsyncytial monolayer• papillary architecture

ll l i l

intranuclear pseudoinclusions

• dense cytoplasm• cellular swirls• enlarged, oval

• dense cytoplasm• marginal μnucleoli

nucleus• fine, pale chromatin

• MG cells• psammoma bodies, p

• longitudinal nucleargrooves

p• “bubble-gum”

colloidgrooves colloid

Page 45: thyroid bethesda
Page 46: thyroid bethesda
Page 47: thyroid bethesda
Page 48: thyroid bethesda
Page 49: thyroid bethesda
Page 50: thyroid bethesda
Page 51: thyroid bethesda

Clinical Management Algorithms

• Benign • FLUS–follow

• Suspicious– repeat FNAN di ti• Suspicious

–surgery• Non-diagnostic

(includes “cyst fluid • Malignant

surgery

only”)– repeat FNA–surgery repeat FNA

• usually after 3 monthsmonths

Page 52: thyroid bethesda

Goitered GazelleGoitered GazelleGazella subgutturosa